Residual dyslipidemia among united states adults treated with lipid modifying therapy (data from national health and nutrition examination survey 2009-2010)

American Journal of Cardiology

Volumn 112, Issue 3, 2013, Pages 373-379

  Wong, Nathan D ^a   Chuang, Joanna ^a   Wong, Kalina ^a   Pham, Amy ^a   Neff, David ^b   Marrett, Elizabeth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DYSLIPIDEMIA; FEMALE; GOAL ATTAINMENT; HEALTH CARE SURVEY; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; UNITED STATES;

ADULT; AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GOALS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; NUTRITION SURVEYS; REFERENCE VALUES; TREATMENT OUTCOME; TRIGLYCERIDES; UNITED STATES;

EID: 84880328997     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.041     Document Type: Article

References (28)

1. J.D. Cohen, M.J. Cziraky, Q. Cai, A. Wallace, T. Waiser, J.R. Crouse, and T.A. Jacobson 30-Year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II III, and 1999-2006 Am J Cardiol 106 2010 969 975
2. H. Ghandehari, S. Kamal-Bahl, and N.D. Wong Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004 Am Heart J 156 2008 112 119
3. S. Malik, V. Lopez, R. Chen, W. Wu, and N.D. Wong Undertreatment of cardiovascular risk factors among persons with diabetes in the United States Diabetes Res Clin Pract 77 2007 126 133
4. M.J. Jacobs, T. Kleisli, J.R. Pio, S. Malik, G.J. L'Italien, R.S. Chen, and N.D. Wong Prevalence and control of dyslipidemia among persons with diabetes in the United States Diabetes Res Clin Pract 70 2005 263 269
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
6. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternack, S.C. Smith Jr., N.J. Stone Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
7. NHANES 1999-2000 Laboratory/Medical Technologists Procedures Manual Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention.
8. R.B. D'Agostino, S.V. Ramachandran, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, and W.B. Kannel General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
9. S.C. Smith Jr., J. Allen, S.N. Blair, R.O. Bonow, L.M. Brass, G.C. Fonarow, S.M. Grundy, L. Hiratzka, D. Jones, H.M. Krumholz, L. Mosca, R.C. Pasternak, T. Pearson, M.A. Pfeffer, K.A. Taubert, and National Heart Lung and Blood Institute AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
10. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis 49 2007 S13 S154
11. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, F. Costa, and American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
12. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
13. J. Drozda, J.M. Messer, J. Spertus, J. Drozda Jr., J.V. Messer, J. Spertus, B. Abramowitz, K. Alexander, C.T. Beam, R.O. Bonow, J.S. Burkiewicz, M. Crouch, D.C. Goff Jr., R. Hellman, T. James III, M.L. King, E.A. Machado Jr., E. Ortiz, M. O'Toole, S.D. Persell, J.M. Pines, F.J. Rybicki, L.B. Sadwin, J.D. Sikkema, P.K. Smith, P.J. Torcson, and J.B. Wong ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance improvement J Am Coll Cardiol 58 2011 316 336
14. P.J. Libby The forgotten majority: unfinished business in cardiovascular risk reduction J Am Coll Cardiol 46 2005 1225 1228
15. P. Barter, A.M. Gotto, J.C. LaRosa, J. Maroni, M. Szarek, S.M. Grundy, J.J. Kastelein, V. Bittner, J.C. Fruchart, and Treating to New Targets Investigators HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events N Engl J Med 357 2007 1301 1310
16. A. Sachdeva, C.P. Cannon, P.C. Deedwania, K.A. Labresh, S.C. Smith Jr., D. Dai, A. Hernandez, and G.C. Fonarow Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With the Guidelines Am Heart J 157 2009 111 117
17. S.S. Virani, L. Steinberg, T. Murray, S. Negi, V. Nambi, L.D. Woodard, B. Bozkurt, L.A. Petersen, and C.M. Ballantyne Barriers to non-HDL cholesterol goal attainment by providers Am J Med 124 2011 876 880
18. S.S. Nag, G.W. Daniel, M.F. Bullano, S. Kamal-Bahl, S.G. Sajjan, H. Hu, and C. Alexander LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO J Manag Care Pharm 13 2007 652 663
19. A.A. Alsheikh-Ali, J.L. Lin, P. Abourjaily, D. Ahearn, J.T. Kuvin, and R.H. Karas Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol Am J Cardiol 100 2007 1499 1501
20. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, N.K. Wenger Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
21. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and A.M. Gotto Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels JAMA 279 1998 1615 1622
22. U. Javed, P.C. Deedwania, D.L. Bhatt, C.P. Cannon, D. Dai, A. Hernandez, E.D. Peterson, and G.C. Fonarow Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participate in Get With the Guidelines (GWTG) Am Heart J 161 2011 418 424
23. A. Kumar, G.C. Fonarow, K.A. Eagle, A.T. Hirsch, R.M. Califf, M.J. Alberts, W.E. Boden, P.G. Steg, M. Shao, D.L. Bhatt, C.P. Cannon, and REACH Investigators Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry Crit Pathw Cardiol 8 2009 104 111
24. S.L. Stadler, B. Bhardwaja, K.L. Olson, J.D. Powers, and D. Lanese An assessment of cholesterol goal attainment in patients with chronic kidney disease J Clin Lipidol 4 2010 298 304
25. J.J. Synder, and A.J. Collins KDOQI hypertension, dyslipidemia and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004 Am J Nephrol 30 2009 44 54
26. R.L. Sacco, R. Adams, G. Albers, M.J. Alberts, O. Benavente, K. Furie, L.B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, S.C. Johnston, I. Katzan, M. Kelly-Hayes, E.J. Kenton, M. Marks, L.H. Schwamm, T. Tomsick American Heart Association American Stroke Association Council on Stroke Council on Cardiovascular Radiology and Intervention American Academy of Neurology Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention Stroke 37 2006 577 617
27. T.W. Rooke, A.T. Hirsch, S. Misra, A.N. Sidawy, J.A. Beckman, L.K. Findeiss, J. Golzarian, H.L. Gornik, J.L. Halperin, M.R. Jaff, G.L. Moneta, J.W. Olin, J.C. Stanley, C.J. White, J.V. White, R.E. Zierler Society for Cardiovascular Angiography and Interventions Society of Interventional Radiology Society for Vascular Medicine Society for Vascular Surgery ACCF/AHA focused update of the guideline for the management of patients with peripheral arterial disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2020 2045
28. C. Baigent, M.J. Landray, C. Reith, J. Emberson, D.C. Wheeler, C. Tomson, C. Wanner, V. Krane, A. Cass, J. Craig, B. Neal, L. Jiang, L.S. Hooi, A. Levin, L. Agodoa, M. Gaziano, B. Kasiske, R. Walker, Z.A. Massy, B. Feldt-Rasmussen, U. Krairittichai, V. Ophascharoensuk, B. Fellström, H. Holdaas, V. Tesar, A. Wiecek, D. Grobbee, D. de Zeeuw, C. Grönhagen-Riska, T. Dasgupta, D. Lewis, W. Herrington, M. Mafham, W. Majoni, K. Wallendszus, R. Grimm, T. Pedersen, J. Tobert, J. Armitage, A. Baxter, C. Bray, Y. Chen, Z. Chen, M. Hill, C. Knott, S. Parish, D. Simpson, P. Sleight, A. Young, R. Collins, and SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192